BCL2 and colorectal carcinoma: For example, miR-139-5p and miR195-5p remarkably inhibited the metastatic capacity and chemoresistance of CRC by targeting BCL2 and glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5), respectively (40, 41).